Blog

How Alpha Analyst is redefining investment research. Insights, team perspectives, and the latest on building AI for finance.

Seagate stock price targets after earnings: a practical playbook

Seagate stock price targets after earnings: a practical playbook

How to translate analyst target changes into an actionable upside range, grounded in filings and updated as the Street revises its view

Short-Seller Reports on Carvana: A Due Diligence Playbook

Short-Seller Reports on Carvana: A Due Diligence Playbook

How to stress-test accounting claims, related-party dependence, and “beat-and-raise” narratives with filings-first research

BBAI partnership news: how to analyze customs AI deals fast

BBAI partnership news: how to analyze customs AI deals fast

A practical research workflow for verifying headlines, mapping revenue impact, and monitoring follow-on filings in Alpha Analyst

NTLA stock jump: what the FDA clinical hold lift means

NTLA stock jump: what the FDA clinical hold lift means

A practical explainer of Intellia’s MAGNITUDE-2 update, the key risks to track next, and how to monitor trial and regulatory signals in Alpha Analyst

Amazon Fresh and Amazon Go Closures: Investor Research Playbook

Amazon Fresh and Amazon Go Closures: Investor Research Playbook

What the Whole Foods expansion signals, what to verify in filings, and how to monitor next steps in Alpha Analyst

Tesla brand value drop in 2025: What it signals for investors

Tesla brand value drop in 2025: What it signals for investors

How to turn a headline about brand perception into a repeatable monitoring workflow

IonQ–SkyWater deal: what was announced and how to research it

IonQ–SkyWater deal: what was announced and how to research it

A practical M&A-read checklist, key terms to track, and an Alpha Analyst workflow for staying ahead of the filings

MNKD stock jump explained: Afrezza label update and what to watch next

MNKD stock jump explained: Afrezza label update and what to watch next

A practical catalyst breakdown for MannKind investors, plus a workflow to track FDA-driven moves in Alpha Analyst

IBRX Volatility: How to Read “Median OS Not Reached” Updates

IBRX Volatility: How to Read “Median OS Not Reached” Updates

A biotech catalyst checklist using ImmunityBio’s glioblastoma Phase 2 headline as a case study